Showing 471-480 of 2105 results for "".
- Vascular Clinichttps://practicalneurology.com/diseases-diagnoses/stroke/PN0505Vascular-pdf/31460/Intracranial stenosis, responsible for 10-15% of all strokes and more prevalent among non-Caucasian populations such as Asians and African Americans, remains a critical yet under-researched area in vascular neurology. Historically, the medical management of intracranial stenosis lacked robust prospe
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0505PainManagement-pdf/31457/Interventional pain management procedures are increasingly integral to comprehensive neurological care, yet many neurologists without a chronic pain specialization may hesitate to adopt these techniques. Understanding the indications, benefits, and inherent risks of these procedures is crucial for e
- Bringing in the Bucks with Botoxhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0205pg37-40-pdf/31492/Botulinum toxin A (Botox), since its FDA approval in 1989, has become a valuable tool for neurologists, enhancing patient care while contributing to practice revenue. Its approved uses include treating cervical dystonia, intractable migraines, facial nerve disorders, spasmodic dysphonia, hyperhidros
Neuro-Ophthalmology Notions: The Optic Nerve as Topographic Marker in the 2024 McDonald Diagnostic Criteria for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuro-ophthalmology-notions-the-optic-nerve-as-topographic-marker-in-the-2024-mcdonald-diagnostic-criteria-for-multiple-sclerosis/35447/Neuro-ophthalmic evaluations assist in early diagnosis of multiple sclerosis.Is Multiple Sclerosis a White Matter Disease or A Gray Matter Disease?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/is-multiple-sclerosis-a-white-matter-disease-or-a-gray-matter-disease/30105/Damage to myelin, or white matter, is almost always present in multiple sclerosis and the disease has long been thought of as one in which the immune system attacks myelin. Yet damage to the cell that is wrapped in myelin also occurs. As with the chicken or the egg, the experts debate which comes fiSeptember 2016 Video Challenge: A Woman with Slowly Progressive Weakness of the Arms and Legs
https://practicalneurology.com/diseases-diagnoses/neuromuscular/september-2016-video-challenge-a-woman-with-slowl/31093/A 65-year-old woman with 15-year history of slowly progressive weakness of the arms and legs as demonstrated in the video. She had no dysphagia and normal quadriceps strength. CPK level was normal and EMG revealed mixed small and large motor unit potentials in the bilateral distal arm and leg muscleJune 2016 Video Challenge: Subacute Severe Pelvis and Anterior Thigh Pain
https://practicalneurology.com/diseases-diagnoses/neuromuscular/june-2016-video-challenge-subacute-severe-pelvis/31090/A 55-year-old diabetic woman presented with subacute severe right pelvis and anterior thigh pain that was followed by weakness of bilateral quadriceps. Two months later, she experienced weakness of the hip flexors. She had no ankle or knee reflexes. LS MRI showed mild degenerative disease of the spiA Fisherman Who Can Not Peel Shrimp Any More
https://practicalneurology.com/diseases-diagnoses/neuromuscular/a-fisherman-who-can-not-peel-shrimp-any-more/31081/A 21-year-old shrimp peeler developed weakness of his fingers five years earlier that progressed to a degree that was not compatible with his job. He had no neck pain, arm numbness, dysphagia or muscle twitching. Family history was not relevant. Examination is shown. CPK was 530 U/L and EMG revealed- Intervention in Cerebral Venous Thrombosis: Strategies for Successhttps://practicalneurology.com/columns/practice-management/intervention-in-cerebral-venous-thrombosis-strategies-for-success/31039/Cerebral Venous Thrombosis: Clinical Insights and Management StrategiesCerebral venous thrombosis (CVT) represents approximately one percent of all stroke cases in the United States, translating to around 700,000 incidents annually. Unlike typical arterial strokes, CVT predominantly affects a younge
- Levodopa: Life Begins at 40?https://practicalneurology.com/columns/practice-management/levodopa-life-begins-at-40/31189/Levodopa Remains Cornerstone in Parkinson’s Disease Therapy After 40 YearsForty years after the seminal 1967 Cotzias study, levodopa continues to be the primary treatment for Parkinson’s disease (PD), underscoring its enduring efficacy in managing motor symptoms. Levodopa’s journey from a laboratory